Natreon, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: New Brunswick NJ United States (1998)
Status: No NME R&D (1998)

Organization Overview

First Clinical Trial
2011
NCT01311180
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Sanni Raju

Active Ingredients

Drugs in Phase 2 Trials (1)

ashwagandha extract (1 trial)

Drugs in Phase 1 Trials (1)

shilajit extract (2 trials)

Drugs in Other Trials (2)

capros (2 trials)

terminalia chebula (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 4